Investor News

Home>News>Investor News

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+10:00September 23rd, 2020|

Cartherics CEO Alan Trounson celebrates 40 years of the GSK Award for Excellence

Along with others Alan shares his experience in this short clip  ………

 

 

 

2020-09-08T02:41:33+10:00September 8th, 2020|

Fertile Journey: from sheep breeding to IVF babies…and beyond!

Check out this piece about Cartherics co-founder Alan Trounson which ran Sunday on ABC TV’s Landline.

About 10 million babies have been born worldwide through IVF. Many wouldn’t realise a lot of the breakthroughs were made in a woolshed by animal embryologist professor Alan Trounson, stem cell pioneer and co-founder of Cartherics.

https://www.abc.net.au/landline/fertile-journey:-from-sheep-breeding-to-ivf-babies/11970346

 

2020-02-17T02:48:42+11:00February 17th, 2020|

“Who mattered in 2019? When it comes to Science the answer is Cartherics Scientific Advisor Jacques Miller, according to The Age and The Sydney Morning Herald”.

Akshay Venkatesh: this Perth-raised mathematician and professor is “one of Australia’s greatest minds”. Plus: Lisa Harvey-Smith and Jacques Miller.

Good Weekend’s Who Mattered 2019 : Science (by Konrad Marshall 30 November 2019)

Jacques Miller

Every year as Nobel Prize season warms up, Jacques Miller, 88, begins fielding calls from all over the world, all with the same message: […]

2019-12-03T01:38:03+11:00December 3rd, 2019|

Cartherics CEO Alan Trounson answers questions on treating cancer – ‘Can we enclose cancer before it spreads?’

As part of the Australian Academy of Technology and Engineering’s (ATSE) Ask an Expert series from our newsletter #TechKnow, Professor Alan Trounson FTSE answers a question from Celeste, 11, in Victoria.

If cancer starts in a small tumour then spreads around the body, can they make a medicine that encloses the cancer?

Hello Celeste ………

Cancer starts […]

2019-11-26T04:38:06+11:00November 26th, 2019|

Recharging California’s Stem Cell Research Capacity

Image: Robert Klein is finalizing a ballot initiative that asks California voters to re-fund the state’s stem cell agency.

MEDIANEWS GROUP/THE MERCURY NEWS VIA GETTY IMAGES

Cartherics CEO Alan Trounson discusses developments at the agency he headed from 2007-2014

Bob Klein is proposing to bring a second ballot initiative to Californian voters […]

2019-11-21T00:00:53+11:00November 20th, 2019|

Cartherics CEO and IVF Pioneer Alan Trounson joins ABC RN’s Science Friction

A mystery and a minefield: in the 1980s, two Californian millionaires land in Melbourne hoping to have a child using IVF.

No one could have anticipated the incredible saga and debate their case unleashed …….

Here is a direct link to the audio on the website:

https://www.abc.net.au/radionational/programs/sciencefriction/the-trouble-with-embryos/11590280

Here is a link to the second program, which focuses […]

2019-10-25T01:30:55+11:00October 25th, 2019|

Cartherics CEO Alan Trounson discusses how Precision Medicine is changing the DNA of health care

Precision Medicine – Changing the DNA of Health Care

How precision medicine is changing the shape of health – by Alan Trounson

Human disease is generally a consequence of complex interaction between our genes and the environment. Traditionally, medical research focuses on creating therapies to treat specific diseases.

This can be very effective and these therapies can have universal […]

2019-10-21T01:46:54+11:00October 17th, 2019|

The Good Fight

ABC – Australian Story …..

When Newcastle radio host Jill Emberson was told she had terminal ovarian cancer, she opted to go public and go loud.

She discovered her disease was the most neglected and deadliest of all womens’ cancers and vowed to improve awareness and research funding.

Her mission took her from scientific labs, to street protests […]

2019-09-30T08:49:41+10:00September 19th, 2019|
Go to Top